Preview

Опухоли женской репродуктивной системы

Расширенный поиск

Саркомы молочной железы. Обзор литературы

https://doi.org/10.17650/1994-4098-2014-0-2-12-15

Полный текст:

Аннотация

В статье представлен обзор литературных источников, посвященных саркомам (неэпителиальным злокачественным опухолям) молочной железы. По данным различных авторов, саркомы составляют < 1 % всех злокачественных новообразований молочных желез. Эти опухоли вызывают повышенный интерес ученых в связи с их уникальными клинико-морфологическими характеристи- ками и непредсказуемым прогнозом.

Об авторах

Д. А. Рябчиков
ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва
Россия


И. К. Воротников
ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва
Россия


Н. В. Чхиквадзе
ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва
Россия


Е. Е. Миронова
ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва
Россия


М. В. Родионова
ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва
Россия


В. А. Мкртчян
ФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва
Россия


Список литературы

1. McGowan T.S., Cummings B.J., O'Sullivan B. et al. An analysis of 78 breast sarcoma patients without distant metastases at presentation. Int J Radiat Oncol Biol Phys 2000;46(2):383–90.

2. Moore M.P., Kinne D.W. Breast sarcoma. Surg Clin North Am 1996;76(2):383–92.

3. Adem C., Reynolds C., Ingle J.N., Nascimento A.G. Primary breast sarcoma: clinicopathologic series from the Mayo Clinic and review of the literature. Br J Cancer 2004;91(2):237–41.

4. Воротников И.К. Неэпителиальные и фиброэпителиальные опухоли молочной железы: клиника, диагностика, лечение. Дис. ... д-ра мед. наук. М., 2000.

5. Ohta M., Tokuda Y., Kuge S. et al. A case of angiosarcoma of the breast. Jpn J Clin Oncol 1997;27(2):91–4.

6. Hunter T.B., Martin P.C., Dietzen C.D., Tyler L.T. Angiosarcoma of the breast. Two case reports and a review of the literature. Cancer 1985;56(8):2099–106.

7. Merino M.J., Carter D., Berman M. Angiosarcoma of the breast. Am J Surg Pathol 1983;7(1):53–60.

8. Donnell R.M., Rosen P.P., Lieberman P.H. et al. Angiosarcoma and other vascular tumors of the breast. Am J Surg Pathol 1981;5(7): 629–42.

9. Al-Salam S., Balalaa N., Faour I. et al. HIF-1α, VEGF и WT-1 are protagonist in bilateral primary angiosarcoma of breast: a case report and review of literature. Int J Clini Exp Pathol 2012;5(3):247–53.

10. van Geel A.N., den Bakker M.A. Bilateral angiosarcoma of the breast in a fourteen-year- old child. Rare Tumors 2009;28(1):e38.

11. Khoshim M., Sadiq S., Ajarim D., Jamjoom Z.A. Bilateral angiosarcoma of the breast – a case report. Jpn J Surg 1991;21(6):693–95.

12. Greijer A.E., van der Groep P., Kemming D. et al. Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor-1 (HIF-1). J Pathol 2005;206(3):291–304.

13. Dohi S., Ohno S., Ohno Y. et al. WT1 expression correlates with angiogenesis in endometrial cancer tissue. Anticancer Res 2010;30(8):3187–92.

14. Sher T., Hennessy B.T., Valero V. et al. Primary angiosarcomas of the breast. Cancer 2007;110(1):173–8.

15. Nogi H., Kobayashi T., Kawase K. et al. Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case. Surg Today 2007;37(1):38–42.

16. Søndenaa K., Heikkilä R., Nysted A. et al. Diagnosis of brain metastases from a primary hemangiosarcoma of the spleen with magnetic resonance imaging. Cancer 1993;71(1): 138–41.

17. Fernandez Ortega A., Gil Gil J.M., Urruticoetxea A., Serra Payr J.M. Angiosarcoma of the breast. Two cases following breast conserving treatment for invasive carcinoma. Clin Transl Oncol 2006;8(7):536–9.

18. Vemulapalli S., Mita A., Alvarado Y. еt al. The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas. Target Oncol 2011;6(1):29–39. 19. Glazebrook K.N., Magut M.J., Reynolds C. Angiosarcoma of the breast. AJR Am J Roentgenol 2008;190(2):533–8.

19. Zeng W., Styblo T.M., Li S. et al. Breast angiosarcoma: FDG PET findings. Clin Nucl Med 2009;34(7):443–5.

20. Silverman L.R., Deligdisch L., Mandeli J., Greenspan E.M. Chemotherapy for angiosarcoma of the breast: case report of 30 year survival and analysis of the literature. Cancer Invest 1994;12(2):145–55. 22. Georgiannos S.N., Sheaff M. Angiosarcoma of the breast: a 30 year perspective with an optimistic outlook.

21. Br J Plast Surg 2003;56(2):129–34.

22. Johnson C.M., Garguilo G.A. Angiosarcoma of the breast: a case report and literature review. Curr Surg 2002;59(5):490–4.

23. Casper E.S., Waltzman R.J., Schwartz G.K. et al. Phase II trial of paclitaxel in patients with soft-tissue sarcoma. Cancer Invest 1998;16(7):442–6.

24. Fata F., O'Reilly E., Ilson D. et al. Paclitaxel in the treatment of patients with anglosarcoma of the scalp or face. Cancer 1999;86(10):2034–7.

25. Penel N., Bui B.N., Bay J.O. et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008;26(32):5269–74.

26. Hata A., Katakami N., Fujita S. et al. Angiosarcoma arising from right atrium: remarkable response to concurrent chemoradiotherapy with carboplatin and paclitaxel. J Thorac Oncol 2011;6(5):970–1. 28. Vakkalanka B., Milhem M. Paclitaxel as neoadjuvant therapy for high grade angiosarcoma of the spleen: a brief report and literature review. Clin Med Insights Oncol 2010;4:107–10.

27. Rosen A., Thimon S., Ternant D. et al. Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face. Br J Dermatol 2010;163(1):225–7.

28. Azizi A.A., Haberler C., Czech T. et al. Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma. Lancet Oncol 2006;7(6):521–3.

29. Shih T., Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 2006;28(11): 1779–802.

30. Fuller C.K., Charlson J.A., Dankle S.K., Russell T.J. Dramatic improvement of inoperable angiosarcoma with combination paclitaxel and bevacizumab chemotherapy. J Am Acad Dermatol 2010;63(4):е83–4.

31. Park M.S., Ravi V., Araujo D.M. Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol 2010;22(4):351–5.

32. Desbiens C., Hogue J.C., Lévesque Y. Primary breast angiosarcoma: avoiding a common trap. Case Rep Oncol Med 2011;2011:517047.

33. Barr F.G., Chatten J., D’Cruz C.M. et al. Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas. JAMA 1995;273(7):553–7. 36. Li D.L., Zhou R.J., Yang W.T. et al. Rhabdomyosarcoma of the breast: a clinicopathologic study and review of the literature. Chin Med J (Engl) 2012;125(14):2618–22.

34. Errarhay S., Fetohi M., Mahmoud S. еt al. Primary chondrosarcoma of the breast: a case presentation and review of the literature. World J Surg Oncol 2013;11(1):208.

35. Kennedy T., Biggart J.D. Sarcoma of the breast. Br J Cancer 1967;21(4):635–44.

36. Beltaos E., Banerjee T.K. Chondrosarcoma of the breast. Report of two cases. Am J Clin Pathol 1979;71(3):345–9.

37. Thilagavathi G., Subramanian S., Samuel A.V. еt al. Primary chondrosarcoma of the breast. J Indian Med Assoc 1992;90(1):16–7.

38. Guymar S., Ferlicot S., Genestie C. еt al. Breast chondrosarcoma: a case report and review. Ann Pathol 2001;21(2):168–71.


Для цитирования:


Рябчиков Д.А., Воротников И.К., Чхиквадзе Н.В., Миронова Е.Е., Родионова М.В., Мкртчян В.А. Саркомы молочной железы. Обзор литературы. Опухоли женской репродуктивной системы. 2014;(2):12-15. https://doi.org/10.17650/1994-4098-2014-0-2-12-15

For citation:


Ryabchikov D.A., Vorotnikov I.K., Chkhikvadze N.V., Mironova Y.Y., Rodionova M.V., Mkrtchyan V.A. Breast sarcomas. Literature review. Tumors of female reproductive system. 2014;(2):12-15. (In Russ.) https://doi.org/10.17650/1994-4098-2014-0-2-12-15

Просмотров: 245


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1994-4098 (Print)
ISSN 1999-8627 (Online)